1.225DKK-2.00%Mkt Cap: 90.14M $P/E: —Today
BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and …
Industry Peers
Diagnostics & Research$226.85BUSDP/E 33.1
$142.58BUSDP/E 38.5
$151.78BUSDP/E 38.6
$46.70BUSDP/E 37.9
$46.86BUSD
$44.35BUSDP/E 39.5
$44.14BUSDP/E 31.4
$41.03BUSDP/E 31.0
$40.83BUSDP/E 105.8
$30.40BUSDP/E 40.4
$30.95BUSDP/E 38.2
$28.55BUSDP/E 32.1
$26.80BUSDP/E 27.4
$26.68BUSDP/E 25.6
$21.92BUSD
$16.98BUSDP/E 35.8
$13.65BUSDP/E 25.3
$13.84BUSD
$13.33BUSDP/E 57.4
$9.55BUSDP/E 19.1
| Headline | Source | Time |
|---|---|---|
Older | ||